Alecia A. Decoudreaux

CIK: 0001233354

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CVS

CVS HEALTH Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

CVS
CVS HEALTH Corp
May 14, 2026
Award(A)
Deferred Stock Units
Direct
1.4K shares at avg. $97.15-
CVS
CVS HEALTH Corp
Nov 20, 2025
Award(A)
Deferred Stock Units
Direct
1.7K shares at avg. $76.04-
CVS
CVS HEALTH Corp
May 15, 2025
Award(A)
Deferred Stock Units
Direct
2.1K shares at avg. $60.47-
CVS
CVS HEALTH Corp
Nov 21, 2024
Award(A)
Deferred Stock Units
Direct
2.2K shares at avg. $57.10-

		Type	Shares	Price		Ownership
May 14, 2026	CVS CVS HEALTH Corp	Award(A) Deferred Stock Units	1,448	$97.15	-	Direct
Nov 20, 2025	CVS CVS HEALTH Corp	Award(A) Deferred Stock Units	1,652	$76.04	-	Direct
May 15, 2025	CVS CVS HEALTH Corp	Award(A) Deferred Stock Units	2,077	$60.47	-	Direct
Nov 21, 2024	CVS CVS HEALTH Corp	Award(A) Deferred Stock Units	2,200	$57.10	-	Direct

1-4 of 4 transactions

About DECOUDREAUX ALECIA A

DECOUDREAUX ALECIA A (SEC CIK 0001233354) files insider reports with the SEC as Director of CVS HEALTH Corp (CVS).

Signal8 holds 4 ownership filings by DECOUDREAUX ALECIA A, all Form 4s, filed between Nov 25, 2024 and May 15, 2026. Those filings report 4 transactions, from Nov 21, 2024 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DECOUDREAUX ALECIA A's filings is in WOONSOCKET, RI.

Recent filings by DECOUDREAUX ALECIA A

May 14, 2026: Grant or award of CVS derivative securities (Form 4, code A).
Nov 20, 2025: Grant or award of CVS derivative securities (Form 4, code A).
May 15, 2025: Grant or award of CVS derivative securities (Form 4, code A).
Nov 21, 2024: Grant or award of CVS derivative securities (Form 4, code A).

Other insiders filing for CVS HEALTH Corp (CVS)

Clark James David, SVP, Cont & Chief Acct Officer
Newman Brian, EVP, Chief Financial Officer
Compton-Phillips Amy, EVP, Chief Medical Officer
AGUIRRE FERNANDO, Director
ROBBINS LARRY, Director
Gallina John E, Director

How to read Form 4 transaction codes